CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 82 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,704 | -36.8% | 10,842 | -4.4% | 0.00% | – |
| Q4 2022 | $7,442 | -50.4% | 11,341 | -36.9% | 0.00% | – |
| Q3 2022 | $15,000 | +50.0% | 17,968 | -2.2% | 0.00% | – |
| Q2 2022 | $10,000 | -50.0% | 18,368 | +0.5% | 0.00% | – |
| Q1 2022 | $20,000 | -54.5% | 18,268 | -28.6% | 0.00% | – |
| Q4 2021 | $44,000 | -57.7% | 25,568 | -24.7% | 0.00% | – |
| Q3 2021 | $104,000 | +188.9% | 33,968 | +272.7% | 0.00% | – |
| Q2 2021 | $36,000 | +71.4% | 9,114 | +22.6% | 0.00% | – |
| Q1 2021 | $21,000 | +425.0% | 7,434 | +547.6% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 1,148 | +675.7% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 148 | -52.4% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 311 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 325,000 | $861,000 | 4.66% |
| MFN Partners Management, LP | 2,427,677 | $6,433,000 | 0.85% |
| EcoR1 Capital, LLC | 2,742,276 | $7,267,000 | 0.76% |
| Slate Path Capital LP | 1,196,063 | $3,170,000 | 0.24% |
| Eversept Partners, LP | 337,145 | $893,434 | 0.22% |
| Artal Group S.A. | 1,861,584 | $4,933,000 | 0.21% |
| Alambic Investment Management, L.P. | 21,265 | $56,000 | 0.14% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 198,106 | $525,000 | 0.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 124,976 | $331,000 | 0.04% |
| Broderick Brian C | 32,175 | $86,000 | 0.03% |